Arvind is a global leader in studying impacts on the macroeconomy under several crises, including the impacts of the COVID-19 crisis, Russia’s invasion of Ukraine, and recent inflation and elevated interest rates. He has focused on understanding the changes in global asset valuations relative to productivity as part of the McKinsey Global Institute’s global balance sheets research series.
Arvind previously was a leader in McKinsey’s Risk & Resilience practice and served a range of financial and non-financial institutions (e.g., banks, asset managers, oil, gas, and chemical producers, pharmaceutical makers, industrials, and utilities). In addition to scenario work, he helped clients use those scenarios and subsequent analytics to better manage their balance sheet, portfolio, and P&L. He also co-led McKinsey’s capital and balance sheet management service line and the credit service line (within the Risk & Resilience Practice) in the Americas.
Arvind is a board member of the Singala Institute, a mental health care nonprofit. Prior to joining McKinsey, he was a neuroscientist at the Massachusetts Institute of Technology, where he was the Assistant Director at the RIKEN-MIT-Picower Center for Neural Circuit Genetics. Arvind has a PhD from the Massachusetts Institute of Technology in Biology and a Bachelor of Science degree from the University of Toronto in chemistry, biochemistry, and computer science.
